Activation of amino acid metabolic program in cardiac HIF1-alpha-deficient mice
Ivan Menendez-Montes,
Beatriz Escobar,
Manuel J. Gomez,
Teresa Albendea-Gomez,
Beatriz Palacios,
Elena Bonzon-Kulichenko,
Jose Luis Izquierdo-Garcia,
Ana Vanessa Alonso,
Alessia Ferrarini,
Luis Jesus Jimenez-Borreguero,
Jesus Ruiz-Cabello,
Jesus Vázquez,
Silvia Martin-Puig
Affiliations
Ivan Menendez-Montes
Myocardial Pathophysiology Area. National Center for Cardiovascular Research, Melchor Fernandez Almagro 3, 28029 Madrid, Spain; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA
Beatriz Escobar
Myocardial Pathophysiology Area. National Center for Cardiovascular Research, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
Manuel J. Gomez
Bioinformatics Unit. National Center for Cardiovascular Research. Madrid, Spain
Teresa Albendea-Gomez
Myocardial Pathophysiology Area. National Center for Cardiovascular Research, Melchor Fernandez Almagro 3, 28029 Madrid, Spain; Facultad de Medicina. Universidad Francisco de Vitoria, Madrid, Spain
Beatriz Palacios
Myocardial Pathophysiology Area. National Center for Cardiovascular Research, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
Elena Bonzon-Kulichenko
Vascular Pathophysiology Area. National Center for Cardiovascular Research. Madrid, Spain
Jose Luis Izquierdo-Garcia
Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), 20014 Donostia San Sebastián, Spain; CIBER de Enfermedades Respiratorias (CIBERES), 28029 Madrid, Spain; Departamento de Química en Ciencias Farmaceuticas. Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain
Ana Vanessa Alonso
Advanced Imaging Unit. National Center for Cardiovascular Research. Madrid, Spain
Alessia Ferrarini
Vascular Pathophysiology Area. National Center for Cardiovascular Research. Madrid, Spain
Luis Jesus Jimenez-Borreguero
Advanced Imaging Unit. National Center for Cardiovascular Research. Madrid, Spain; Cardiology Unit, Hospital Universitario de La Princesa, Madrid, Spain
Jesus Ruiz-Cabello
Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), 20014 Donostia San Sebastián, Spain; CIBER de Enfermedades Respiratorias (CIBERES), 28029 Madrid, Spain; Departamento de Química en Ciencias Farmaceuticas. Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain; IKERBASQUE, Basque Foundation for Science, 48013 Bilbao, Spain
Jesus Vázquez
Vascular Pathophysiology Area. National Center for Cardiovascular Research. Madrid, Spain; CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain
Silvia Martin-Puig
Myocardial Pathophysiology Area. National Center for Cardiovascular Research, Melchor Fernandez Almagro 3, 28029 Madrid, Spain; Facultad de Medicina. Universidad Francisco de Vitoria, Madrid, Spain; Corresponding author
Summary: HIF1-alpha expression defines metabolic compartments in the developing heart, promoting glycolytic program in the compact myocardium and mitochondrial enrichment in the trabeculae. Nonetheless, its role in cardiogenesis is debated. To assess the importance of HIF1-alpha during heart development and the influence of glycolysis in ventricular chamber formation, herein we generated conditional knockout models of Hif1a in Nkx2.5 cardiac progenitors and cardiomyocytes. Deletion of Hif1a impairs embryonic glycolysis without influencing cardiomyocyte proliferation and results in increased mitochondrial number and transient activation of amino acid catabolism together with HIF2α and ATF4 upregulation by E12.5. Hif1a mutants display normal fatty acid oxidation program and do not show cardiac dysfunction in the adulthood. Our results demonstrate that cardiac HIF1 signaling and glycolysis are dispensable for mouse heart development and reveal the metabolic flexibility of the embryonic myocardium to consume amino acids, raising the potential use of alternative metabolic substrates as therapeutic interventions during ischemic events.